High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.3M
$1,251,030
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Welgus Howard G.
• Director
10b5-1 SellΔOwn -16.7%
2026-03-02
$256,518
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -16.7%
|
2026-03-02 | $256,518 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Welgus Howard G.
• Director
10b5-1 SellΔOwn -14.3%
2026-02-02
$250,483
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -14.3%
|
2026-02-02 | $250,483 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Welgus Howard G.
• Director
10b5-1 SellΔOwn -11.1%
2025-12-01
$302,133
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -11.1%
|
2025-12-01 | $302,133 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Welgus Howard G.
• Director
10b5-1 SellΔOwn -10.0%
2025-11-03
$252,669
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -10.0%
|
2025-11-03 | $252,669 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-10-01 | $180,485 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
Other
|
2025-10-01 | $16,030 | M | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-10-01 | $8,742 | S | Form 4 |